. 2019 Apr 11;2019:2737968. doi: 10.1155/2019/2737968

Table 2.

Outcomes of ocular surface and MGs parameters in Cohort II.

Parameters	Mean±SD				P-value
	Baseline	Pre-op	1 month	3 months	Overrall^c	Pre-op VS	1M VS	3M VS
	Baseline	Pre-op	1 month	3 months	Overrall^c	Baseline	Baseline	Baseline
OSS^a	2.37±1.40	1.15±0.77	3.04±1.13	2.37±1.01	0.052	<0.001∗∗∗	0.164	>0.999

NIKBUT(s)^a	4.48±1.48	6.41±1.19	2.81±2.18	4.96±1.68	<0.001∗∗∗	<0.001∗∗∗	0.003∗∗	0.989

Corneal FL^b	0.67±0.73	0.63±0.56	0.59±0.64	0.70±0.61	0.821	0.836	>0.999	>0.999

Schirmer(mm)^a	6.11±1.76	6.63±2.00	6.07±2.15	6.48±1.40	0.655	0.317	>0.999	>0.999

Lid margin^b	2.56±0.51	0.59±0.57	2.30±0.72	2.41±0.64	0.320	<0.001∗∗∗	0.401	>0.999

Meibum quality^b	3.07±1.49	1.48±0.80	2.96±0.90	2.81±1.14	0.730	<0.001∗∗∗	>0.999	>0.999

Expressibility^b	2.74±0.81	1.15±0.72	2.26±0.81	2.81±0.83	0.030	<0.001∗∗∗	0.102	>0.999

Meibography^b	2.67±0.73	2.52±0.64	2.56±0.80	2.59±0.69	0.856	0.434	>0.999	>0.999

^aContinuous values were analyzed by linear mixed model with Bonferroni post hoc analysis. ^bNoncontinuous values were analyzed by generalized linear mixed model analysis with Bonferroni post hoc analysis. ^cThe overall analysis included baseline and 1 month and 3 months postoperatively (∗∗∗P < 0.001, ∗∗P < 0.01, ∗P < 0.05).